Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引：0
|
作者：
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构：
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1569 / 1570
页数：1
相关论文
共 50 条
  • [1] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Epis, Oscar
    Casu, Cinzia
    Belloli, Laura
    Schito, Emanuela
    Filippini, Davide
    Muscara, Marina
    Bruschi, Eleonora
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1569 - 1570
  • [2] IDENTIFICATION OF SYNOVITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION DURING THERAPY WITH TOCILIZUMAB
    Panasyuk, E.
    Smirnov, A.
    Fedorenko, E.
    Gavva, T.
    Gubar, E.
    Loginova, E.
    Lukina, G.
    Luchikhina, E.
    Tsvetkova, E.
    Avdeeva, A.
    Alexandrova, E.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 508 - 509
  • [3] MOLECULAR SIGNATURE IN SUSTAINED CLINICAL REMISSION INDUCED BY TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kajio, N.
    Suzuki, K.
    Matsumoto, K.
    Iijima, H.
    Nakamura, S.
    Ishizawa, Y.
    Inamo, J.
    Takeshita, M.
    Yoshimoto, K.
    Kaneko, Y.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 526 - 526
  • [4] LOW DOSE OF RITUXIMAB IS EFFECTIVE FOR MAINTENANCE OF CLINICAL REMISSION OR LOW DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Argoustidis, N.
    Flouri, I.
    Adamichou, C.
    Kabouraki, E.
    Eskitzis, A.
    Kyfonidou, P.
    Papalopoulos, I.
    Fanouriakis, A.
    Repa, A.
    Kougkas, N.
    Bertsias, G.
    Sidiropoulos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 577
  • [5] Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial
    Sanmarti, Raimon
    Veale, Douglas J.
    Martin-Mola, Emilio
    Escudero-Contreras, Alejandro
    Gonzalez, Carlos
    Ercole, Liliana
    Alonso, Rocio
    Fonseca, Joao E.
    Alcaniz, Cristina
    Maria Alvaro-Gracia, Jose
    Balsa, Alejandro
    Luis de Pablos, Jose
    Diaz Miguel, Consuelo
    Manuel Rodriguez, Jose
    Alves, Jose
    Aurrecoechea, Elena
    Calvo, Jaime
    Belzunegui, Joaquin
    Blanco, Francisco
    Caliz, Rafael
    Calvo, Javier
    Roman Ivorra, Jose
    Canhao, Helena
    Santos, Helena
    Chamizo, Eugenio
    del Pino, Javier
    Delgado, Concepcion
    Diaz, Cesar
    Fernandez Nebro, Antonio
    Fraser, Alexander
    Gomez, Antonio
    Hernandez, Blanca
    Navarro, Federico
    Pov-Marras, Juan
    Moreno, Juan
    Perez Venegas, Jose
    Pombo, Manuel
    Riera, Elena
    Rosas, Antonio
    Ryan, John
    Santos, Jose
    Santos, Maria
    Tornero, Jesus
    Victor Tovar, Juan
    Ucar, Eduardo
    Vasconcelos, Carlos
    Veiga, Raul
    Vela, Paloma
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (10) : 1616 - 1625
  • [6] Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Rheumatoid Arthritis Patients.
    Vargas-Serafin, Cesar
    Aguilar-Lozano, Luis
    Padilla-Ibarra, Jorge
    Sandoval-Castro, Carlos
    Dionisio Castillo-Ortiz, Jose
    Morales-Torres, Jorge
    Hernandez, Claudia
    Ramos-Remus, Cesar
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S193 - S193
  • [7] Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid Arthritis
    Aguilar-Lozano, Luis
    Dionisio Castillo-Ortiz, Jose
    Vargas-Serafin, Cesar
    Morales-Torres, Jorge
    Sanchez-Ortiz, Adriana
    Sandoval-Castro, Carlos
    Padilla-Ibarra, Jorge
    Hernandez-Cuevas, Claudia
    Ramos-Remus, Cesar
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1069 - 1073
  • [8] DISCONTINUATION OF TOCILIZUMAB AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nampei, A.
    Nagayama, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [9] Prospective Study about Extension of Dosing Interval with Tocilizumab Therapy in Rheumatoid Arthritis Patients in Remission Maintenance
    Kikuchi, Jun
    Shibata, Akiko
    Sakai, Ryota
    Chino, Kentaro
    Kondo, Tsuneo
    Okuyama, Ayumi
    Takei, Hirofumi
    Amano, Koichi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
    Best, Jennie H.
    Abbass, Ibrahim
    Tominna, Lenore
    Reiss, William
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 72 - 73
12345